Institution · Pulmonary Hypertension Association
Most cited papers from Pulmonary Hypertension Association
What are the most cited papers from Pulmonary Hypertension Association?
The most cited paper from Pulmonary Hypertension Association is "Inhibition of VEGF receptors causes lung cell apoptosis and emphysema" (Yasunori Kasahara, Rubin M. Tuder, Laimute Taraseviciene‐Stewart et al., 2000), with 1,124 citations. Next come "Comprehensive Invasive and Noninvasive Approach to the Right Ventricle–Pulmonary Circulation Unit" (471) and "Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B" (366).
Showing 50 of 60 papers. Every paper with more than 50 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Inhibition of VEGF receptors causes lung cell apoptosis and emphysema Yasunori Kasahara, Rubin M. Tuder, Laimute Taraseviciene‐Stewart et al. · Journal of Clinical Investigation | Dec 2000 | 1,124 |
| 2 | Comprehensive Invasive and Noninvasive Approach to the Right Ventricle–Pulmonary Circulation Unit Hunter C. Champion, Evangelos D. Michelakis, Paul M. Hassoun · Circulation | 14 Sep 2009 | 471 |
| 3 | Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B Steven W. Pipe et al. · New England Journal of Medicine | 22 Feb 2023 | 366 |
| 4 | Malignant pheochromocytoma: current status and initiatives for future progress Graeme Eisenhofer, Stefan Richard Bornstein, Frederieke M. Brouwers et al. · Endocrine Related Cancer | Sep 2004 | 337 |
| 5 | Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension Carlyne D. Cool, Pradeep R. Rai, Michael E. Yeager et al. · New England Journal of Medicine | 17 Sep 2003 | 295 |
| 6 | Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Peter Dorfmüller, Sven Günther, Maria‐Rosa Ghigna et al. · European Respiratory Journal | 19 Aug 2014 | 285 |
| 7 | Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia Tamera J. Corte, Gregory J. Keir, Konstantinos Dimopoulos et al. · American Journal of Respiratory and Critical Care Medicine | 17 Jun 2014 | 227 |
| 8 | Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017) Keiichi Fukuda et al. · Circulation Journal | 8 Mar 2019 | 226 |
| 9 | Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension Mark W. Geraci, Bifeng Gao, David C. Shepherd et al. · Journal of Clinical Investigation | Jun 1999 | 225 |
| 10 | Primary Pulmonary Hypertension Between Inflammation and Cancer Norbert Felix Voelkel, Carlyne D. Cool, S.D. Lee et al. · CHEST Journal | Sep 1998 | 221 |
| 11 | Genetic basis of sitosterolemia Mi‐Hye Lee, Kangmo Lu, Shailesh B. Patel · Current Opinion in Lipidology | Apr 2001 | 197 |
| 12 | Categorization and impact of pulmonary hypertension in patients with advanced COPD Michael J. Cuttica, Ravi Kalhan, Oksana A. Shlobin et al. · Respiratory Medicine | 15 Jun 2010 | 179 |
| 13 | Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway Ethan David Cohen, Kaori Ihida‐Stansbury, Min M. Lu et al. · Journal of Clinical Investigation | 13 Aug 2009 | 179 |
| 14 | Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension Ekkehard Grünig, Nicola Ehlken, Hossein Ardeschir Ghofrani et al. · Respiration | 2011 | 174 |
| 15 | An Overview of Pheochromocytoma William Muir Manger · Annals of the New York Academy of Sciences | Aug 2006 | 165 |
| 16 | British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations Claire L. Shovlin, Robin Condliffe, James W. Donaldson et al. · Thorax | 15 Nov 2017 | 158 |
| 17 | Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives Loı̈c Guillevin, Iain J. Armstrong, Rino Aldrighetti et al. · European Respiratory Review | 29 Nov 2013 | 158 |
| 18 | Pheochromocytoma William Muir Manger, Ray W. Gifford · Journal of Clinical Hypertension | 2002 | 143 |
| 19 | Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review Sindhu R. Johnson, Sanjay Kumar Mehta, John Thomas Granton · European Respiratory Journal | 30 Oct 2006 | 142 |
| 20 | Limitations to the 6-Minute Walk Test in Interstitial Lung Disease and Pulmonary Hypertension in Scleroderma Margaret C. Garin, Kristin B. Highland, Richard M. Silver et al. · The Journal of Rheumatology | 22 Jan 2009 | 135 |
| 21 | The importance of patient perspectives in pulmonary hypertension Michael D. McGoon, Pisana Ferrari, Iain J. Armstrong et al. · European Respiratory Journal | 13 Dec 2018 | 123 |
| 22 | Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension Aimee K. Doran, D. Dunbar Ivy, Robyn J. Barst et al. · International Journal of Clinical Practice | 4 Jul 2008 | 121 |
| 23 | Circulating endothelial cells in pulmonary hypertension Heiko A Golpon, Robert P. Hebbel, Anna N. Solovey et al. · Thrombosis and Haemostasis | 2003 | 119 |
| 24 | STAT3 signaling in pulmonary arterial hypertension Roxane Paulin, Jolyane Meloche, Sébastien Bonnet · JAK-STAT | Oct 2012 | 116 |
| 25 | Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement Laura Price et al. · British Journal of Anaesthesia | 20 Feb 2021 | 112 |
| 26 | Pathobiology of pulmonary arterial hypertension Saadia Eddahibi, Nicholas W. Morrell, Marie‐Pia d’Ortho et al. · European Respiratory Journal | Dec 2002 | 108 |
| 27 | Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension Panagiota Xanthouli, Suzana Jordan, Nicklas Milde et al. · Annals of the Rheumatic Diseases | 9 Dec 2019 | 107 |
| 28 | The Protean Manifestations of Pheochromocytoma William Muir Manger · Hormone and Metabolic Research | 25 Feb 2009 | 107 |
| 29 | Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease David Montani, Xavier Jaïs, Laura Price et al. · European Respiratory Journal | 18 Jun 2009 | 104 |
| 30 | Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma Hanadi Dib, Mathieu C. Tamby, Guillaume Bussone et al. · European Respiratory Journal | 17 Oct 2011 | 102 |
| 31 | Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study Carlos Jardim, Carlos Eduardo Rochitte, Marc Humbert et al. · European Respiratory Journal | 29 Nov 2006 | 101 |
| 32 | Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients Deborah Jo Levine · The American Journal of Managed Care | Mar 2021 | 100 |
| 33 | Hypoxia induces different genes in the lungs of rats compared with mice Yasushi Hoshikawa, Patrick S. Nana-Sinkam, Mark D. Moore et al. · Physiological Genomics | 6 Feb 2003 | 93 |
| 34 | An Official American Thoracic Society Statement: Pulmonary Hypertension Phenotypes Raed A. Dweik, Sharon Rounds, SERPIL CEM ERZURUM et al. · American Journal of Respiratory and Critical Care Medicine | Feb 2014 | 88 |
| 35 | Infective endocarditis in adults with congenital heart disease remains a lethal disease Oktay Tutarel, Rafael Alonso-González, Claudia Montanaro et al. · Heart | 28 Jul 2017 | 86 |
| 36 | NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension Rogério Souza, Carlos Jardim, Caio Júlio César dos Santos Fernandes et al. · Respiratory Medicine | 15 Jun 2006 | 84 |
| 37 | Osteonecrosis of the jaws associated with use of risedronate: Report of 2 new cases John K Brooks, Allen J. Gilson, Arnold J. Sindler et al. · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology | 17 Jan 2007 | 83 |
| 38 | The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients Iain J. Armstrong, Catherine Billings, David Gerard Kiely et al. · BMC Pulmonary Medicine | 21 Mar 2019 | 81 |
| 39 | Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience Catherine H. Miele et al. · Annals of the American Thoracic Society | 14 Apr 2016 | 81 |
| 40 | Enhancing Insights into Pulmonary Vascular Disease Through a Precision Medicine Approach. A Joint NHLBI–Cardiovascular Medical Research and Education Fund Workshop Report John H. Newman et al. · American Journal of Respiratory and Critical Care Medicine | 21 Apr 2017 | 79 |
| 41 | Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth Seiichiro Sakao, Laimute Taraseviciene‐Stewart, Kathy Wood et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology | 15 Apr 2006 | 79 |
| 42 | Pheochromocytoma: current diagnosis and management D. G. Vidt, A. Bakst, William Muir Manger et al. · Cleveland Clinic Journal of Medicine | Sep 1993 | 71 |
| 43 | Crystalglobulin-Induced Nephropathy Vinay Kumar Gupta, Mireille El Ters, KIANOUSH B KASHANI et al. · Journal of the American Society of Nephrology | 5 Sep 2014 | 70 |
| 44 | Importance of Angiotensin-Converting Enzyme in Pulmonary Hypertension William T. Abraham, Mary V. Raynolds, B. Andreatta Gottschall et al. · Cardiology | 19 Nov 2008 | 66 |
| 45 | Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension Sylvia M. Nikkho, Manuel Jonas Richter, Eric Shen et al. · Pulmonary Circulation | Jul 2022 | 65 |
| 46 | Pulmonary arterial hypertension associated with congenital heart disease: Recent advances and future directions Michael Athanassios Gatzoulis, Maurice Beghetti, Michael Job Landzberg et al. · International Journal of Cardiology | 28 Sep 2014 | 65 |
| 47 | Could pulmonary arterial hypertension patients be at a lower risk from severe COVID‐19? Evelyn M. Horn, Murali M. Chakinala, Ronald J. Oudiz et al. · Pulmonary Circulation | Apr 2020 | 64 |
| 48 | Clinical Characteristics, Haemodynamics and Treatment of Pulmonary Hypertension in Sarcoidosis in a Single Centre, and Meta-Analysis of the Published Data David Dobarro, Benjamin Emmanuel Schreiber, Clive E Handler et al. · The American Journal of Cardiology | 2013 | 63 |
| 49 | Pulmonary Vascular Manifestations of Mixed Connective Tissue Disease Todd M. Bull, Karen A. Fagan, David B. Badesch · Rheumatic Disease Clinics of North America | Aug 2005 | 63 |
| 50 | Atorvastatin in Pulmonary Arterial Hypertension (APATH) study Weijie Zeng, Changming Xiong, Lan Zhao et al. · European Respiratory Journal | 23 Feb 2012 | 63 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.